Abcellera Biologics Inc (ABCL) — Free Cash Flow Generation Index
Abcellera Biologics Inc (ABCL) has a Free Cash Flow Generation Index of -0.38x as of June 2023. Free cash flow of $-7.53 Million represents 0% of operating cash flow ($19.82 Million). See ABCL current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Abcellera Biologics Inc Free Cash Flow Generation Index (2018–2022)
Historical FCF Generation Index trend for Abcellera Biologics Inc across 5 annual periods. Explore ABCL operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Abcellera Biologics Inc (2018–2022)
Year-by-year Free Cash Flow Generation Index for Abcellera Biologics Inc. For the full company profile including market capitalisation, see market cap of Abcellera Biologics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.74x | $204.70 Million | $277.36 Million | $72.66 Million | ▼ -3.0% |
| 2021 | 0.76x | $186.13 Million | $244.58 Million | $58.45 Million | ▲ +115.4% |
| 2020 | 0.35x | $8.02 Million | $22.69 Million | $14.67 Million | ▲ +173.1% |
| 2019 | -0.48x | $-1.30 Million | $2.69 Million | $4.00 Million | ▲ +1.0% |
| 2018 | -0.49x | $-1.74 Million | $3.56 Million | $5.31 Million | — |